XL-184+Abiraterone in Post-Chemo CRPC
This study is currently recruiting participants.
Verified February 2013 by Dana-Farber Cancer Institute
Sponsor:
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Christopher Sweeney, MBBS, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01574937
First received: April 8, 2012
Last updated: February 19, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | April 2014 |
| Estimated Primary Completion Date: | April 2014 (Final data collection date for primary outcome measure) |